Pfizer raises profit outlook
Strong sales of Prevnar helped the drug maker more than double its quarterly profit. As Fred Katayama reports, one analyst called the results “refreshingly boring.”
Strong sales of Prevnar helped the drug maker more than double its quarterly profit. As Fred Katayama reports, one analyst called the results “refreshingly boring.”